Communiqué de presse
Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer
Strasbourg, France, January 22, 2024, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies […]